Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 524

1.

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.

Ylitalo EB, Thysell E, Thellenberg-Karlsson C, Lundholm M, Widmark A, Bergh A, Josefsson A, Brattsand M, Wikström P.

Prostate. 2019 Dec 4. doi: 10.1002/pros.23935. [Epub ahead of print]

PMID:
31799745
2.

Evaluation and comparison of pain questionnaires for clinical screening of osteoarthritis in cats.

Stadig S, Lascelles DBX, Nyman G, Bergh A.

Vet Rec. 2019 Oct 16. pii: vetrec-2018-105115. doi: 10.1136/vr.105115. [Epub ahead of print]

PMID:
31619513
3.

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.

Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Coenen JLLM, van den Bergh ACMF, Mehra N, Somford DM, Bergman AM, Ten Bokkel Huinink D, Fossion L, Geenen MM, Hendriks MP, van de Luijtgaarden ACM, Polee MB, Weijl NI, van de Wouw AJ, de Wit R, Uyl-de Groot CA, Gerritsen WR.

Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30146-4. doi: 10.1016/j.euo.2019.09.005. [Epub ahead of print]

PMID:
31601523
4.

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands.

Westgeest HM, Kuppen MCP, van den Eertwegh AJM, de Wit R, Coenen JLLM, van den Berg HPP, Mehra N, van Oort IM, Fossion LMCL, Hendriks MP, Bloemendal HJ, van de Luijtgaarden ACM, Ten Bokkel Huinink D, van den Bergh ACMF, van den Bosch J, Polee MB, Weijl N, Bergman AM, Uyl-de Groot CA, Gerritsen WR.

Clin Genitourin Cancer. 2019 Oct;17(5):e946-e956. doi: 10.1016/j.clgc.2019.05.018. Epub 2019 May 31.

PMID:
31439536
5.

TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer.

Aripaka K, Gudey SK, Zang G, Schmidt A, Åhrling SS, Österman L, Bergh A, von Hofsten J, Landström M.

EBioMedicine. 2019 Jul;45:192-207. doi: 10.1016/j.ebiom.2019.06.046. Epub 2019 Jun 28.

6.

In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development.

Zane P, Gieschen H, Kersten E, Mathias N, Ollier C, Johansson P, Van den Bergh A, Van Hemelryck S, Reichel A, Rotgeri A, Schäfer K, Müllertz A, Langguth P.

Eur J Pharm Biopharm. 2019 Sep;142:222-231. doi: 10.1016/j.ejpb.2019.06.010. Epub 2019 Jun 21. Review.

PMID:
31233862
7.

Intersegmental strategies in frontal plane in moderately-skilled riders analyzed in ridden and un-mounted situations.

Engell MT, Byström A, Hernlund E, Bergh A, Clayton H, Roepstorff L, Egenvall A.

Hum Mov Sci. 2019 Jun 13;66:511-520. doi: 10.1016/j.humov.2019.05.021. [Epub ahead of print]

PMID:
31203021
8.

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor.

Thysell E, Vidman L, Ylitalo EB, Jernberg E, Crnalic S, Iglesias-Gato D, Flores-Morales A, Stattin P, Egevad L, Widmark A, Rydén P, Bergh A, Wikström P.

Mol Oncol. 2019 Aug;13(8):1763-1777. doi: 10.1002/1878-0261.12526. Epub 2019 Jun 27.

9.

Reducing maternal deaths by skills-and-drills training in managing obstetric emergencies: A before-and-after observational study.

Pattinson RC, Bergh AM, Ameh C, Makin J, Pillay Y, Van den Broek N, Moodley J.

S Afr Med J. 2019 Mar 29;109(4):241-245. doi: 10.7196/SAMJ.2019.v109i4.13578.

10.

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.

Hammarsten P, Josefsson A, Thysell E, Lundholm M, Hägglöf C, Iglesias-Gato D, Flores-Morales A, Stattin P, Egevad L, Granfors T, Wikström P, Bergh A.

Mod Pathol. 2019 Sep;32(9):1310-1319. doi: 10.1038/s41379-019-0260-6. Epub 2019 Apr 12.

11.

Midwife-led obstetric units working 'CLEVER': Improving perinatal outcome indicators in a South African health district.

Oosthuizen SJ, Bergh AM, Grimbeek J, Pattinson RC.

S Afr Med J. 2019 Jan 31;109(2):95-101. doi: 10.7196/SAMJ.2019.v109i2.13429.

12.

PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model.

Zang G, Mu Y, Gao L, Bergh A, Landström M.

Oncogene. 2019 May;38(22):4215-4231. doi: 10.1038/s41388-019-0722-9. Epub 2019 Jan 31.

13.

Systems thinking: A turning point for improving respectful obstetric care in South African health districts.

Oosthuizen S, Bergh AM, Pattinson RC.

S Afr Med J. 2018 Oct 26;108(11):910-914. doi: 10.7196/SAMJ.2018.v108i11.13312.

14.

Head and pelvic vertical displacement in dogs with induced swinging limb lameness: an experimental study.

Bergh A, Gómez Álvarez CB, Rhodin M, Gustås P.

Acta Vet Scand. 2018 Dec 29;60(1):81. doi: 10.1186/s13028-018-0435-z.

15.

Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.

Adamo H, Hammarsten P, Hägglöf C, Dahl Scherdin T, Egevad L, Stattin P, Halin Bergström S, Bergh A.

Prostate. 2019 Apr;79(5):435-445. doi: 10.1002/pros.23749. Epub 2018 Dec 11.

PMID:
30536410
16.

Barriers to and facilitators for implementing an office ergonomics programme in a South African research organisation.

Koma BS, Bergh AM, Costa-Black KM.

Appl Ergon. 2019 Feb;75:83-90. doi: 10.1016/j.apergo.2018.09.003. Epub 2018 Sep 19.

PMID:
30509541
17.

Postoperative use of somatostatin analogs and mortality in patients with acromegaly.

Postma MR, Wolters TLC, van den Berg G, van Herwaarden AE, Muller Kobold AC, Sluiter WJ, Wagenmakers MA, van den Bergh ACM, Wolffenbuttel BHR, Hermus ARMM, Netea-Maier RT, van Beek AP.

Eur J Endocrinol. 2019 Jan 1;180(1):1-9. doi: 10.1530/EJE-18-0166.

PMID:
30400068
18.

Risk of diabetes after para-aortic radiation for testicular cancer.

Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, Groenewegen G, de Brouwer P, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jóźwiak K, Horenblas S, van Leeuwen FE, Schaapveld M.

Br J Cancer. 2018 Oct;119(7):901-907. doi: 10.1038/s41416-018-0248-x. Epub 2018 Oct 9.

19.

Obstetrics knowledge and skills training as a catalyst for change.

Pattinson RC, Bergh AM, Makin J, Pillay Y, Moodley J, Madaj B, Ameh C, Van den Broek N.

S Afr Med J. 2018 Aug 28;108(9):748-755. doi: 10.7196/SAMJ.2018.v108i9.13073.

20.

The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications.

Iglesias-Gato D, Thysell E, Tyanova S, Crnalic S, Santos A, Lima TS, Geiger T, Cox J, Widmark A, Bergh A, Mann M, Flores-Morales A, Wikström P.

Clin Cancer Res. 2018 Nov 1;24(21):5433-5444. doi: 10.1158/1078-0432.CCR-18-1229. Epub 2018 Jul 24.

21.

Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients.

Schaake W, van der Schaaf A, van Dijk LV, van den Bergh ACM, Langendijk JA.

PLoS One. 2018 Jul 17;13(7):e0197757. doi: 10.1371/journal.pone.0197757. eCollection 2018.

22.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.

J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10.

PMID:
29989856
23.

Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.

Van den Bergh A, Van Hemelryck S, Bevernage J, Van Peer A, Brewster M, Mackie C, Mannaert E.

Mol Pharm. 2018 Jul 2;15(7):2633-2645. doi: 10.1021/acs.molpharmaceut.8b00172. Epub 2018 Jun 11.

PMID:
29799758
24.

Report on an international workshop on kangaroo mother care: lessons learned and a vision for the future.

Cattaneo A, Amani A, Charpak N, De Leon-Mendoza S, Moxon S, Nimbalkar S, Tamburlini G, Villegas J, Bergh AM.

BMC Pregnancy Childbirth. 2018 May 16;18(1):170. doi: 10.1186/s12884-018-1819-9.

25.

'I thought they were going to handle me like a queen but they didn't': A qualitative study exploring the quality of care provided to women at the time of birth.

Lambert J, Etsane E, Bergh AM, Pattinson R, van den Broek N.

Midwifery. 2018 Jul;62:256-263. doi: 10.1016/j.midw.2018.04.007. Epub 2018 Apr 22.

26.

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.

Nordstrand A, Bovinder Ylitalo E, Thysell E, Jernberg E, Crnalic S, Widmark A, Bergh A, Lerner UH, Wikström P.

Int J Mol Sci. 2018 Apr 18;19(4). pii: E1223. doi: 10.3390/ijms19041223.

27.

Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C.

Ingelsson B, Söderberg D, Strid T, Söderberg A, Bergh AC, Loitto V, Lotfi K, Segelmark M, Spyrou G, Rosén A.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E478-E487. doi: 10.1073/pnas.1711950115. Epub 2018 Jan 2.

28.

Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.

Bergström SH, Järemo H, Nilsson M, Adamo HH, Bergh A.

Prostate. 2018 Mar;78(4):257-265. doi: 10.1002/pros.23466. Epub 2017 Dec 18.

PMID:
29250809
29.

Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer.

Gudey SK, Sundar R, Heldin CH, Bergh A, Landström M.

Oncotarget. 2017 Aug 9;8(58):97703-97726. doi: 10.18632/oncotarget.20097. eCollection 2017 Nov 17.

30.

A Systems Approach to Prostate Cancer Classification-Letter.

Thysell E, Ylitalo EB, Jernberg E, Bergh A, Wikström P.

Cancer Res. 2017 Dec 15;77(24):7131-7132. doi: 10.1158/0008-5472.CAN-16-3231. Epub 2017 Dec 6. No abstract available.

31.

Vertical head and pelvic movement symmetry at the trot in dogs with induced supporting limb lameness.

Gómez Álvarez CB, Gustås P, Bergh A, Rhodin M.

Vet J. 2017 Nov;229:13-18. doi: 10.1016/j.tvjl.2017.10.011. Epub 2017 Oct 20.

PMID:
29183568
32.

It does matter where you come from: mothers' experiences of childbirth in midwife obstetric units, Tshwane, South Africa.

Oosthuizen SJ, Bergh AM, Pattinson RC, Grimbeek J.

Reprod Health. 2017 Nov 16;14(1):151. doi: 10.1186/s12978-017-0411-5.

33.

Distributed decision making in action: diagnostic imaging investigations within the bigger picture.

Makanjee CR, Bergh AM, Hoffmann WA.

J Med Radiat Sci. 2018 Mar;65(1):5-12. doi: 10.1002/jmrs.250. Epub 2017 Nov 11.

34.

Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.

Strömvall K, Lundholm M, Thysell E, Bergh A, Halin Bergström S.

PLoS One. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086. eCollection 2017.

35.

Prostate Cancer Detection with a Tactile Resonance Sensor-Measurement Considerations and Clinical Setup.

Åstrand AP, Andersson BM, Jalkanen V, Ljungberg B, Bergh A, Lindahl OA.

Sensors (Basel). 2017 Oct 26;17(11). pii: E2453. doi: 10.3390/s17112453.

36.

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Assel M, Dahlin A, Ulmert D, Bergh A, Stattin P, Lilja H, Vickers AJ.

Eur Urol. 2018 Jun;73(6):961-967. doi: 10.1016/j.eururo.2017.10.004. Epub 2017 Oct 21.

37.

Comparing subjective and objective evaluation of show jumping competition and warm-up arena surfaces.

Hernlund E, Egenvall A, Hobbs SJ, Peterson ML, Northrop AJ, Bergh A, Martin JH, Roepstorff L.

Vet J. 2017 Sep;227:49-57. doi: 10.1016/j.tvjl.2017.09.001. Epub 2017 Sep 11.

38.

Clinical relevance of androgen receptor alterations in prostate cancer.

Jernberg E, Bergh A, Wikström P.

Endocr Connect. 2017 Nov;6(8):R146-R161. doi: 10.1530/EC-17-0118. Review.

39.

Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.

Strömvall K, Sundkvist K, Ljungberg B, Halin Bergström S, Bergh A.

Prostate. 2017 Nov;77(15):1468-1477. doi: 10.1002/pros.23407. Epub 2017 Sep 7.

40.

T-Time: A data repository of T cell and calcium release-activated calcium channel activation imagery.

Arbuckle C, Greenberg M, Bergh A, German R, Sirago N, Linstead E.

BMC Res Notes. 2017 Aug 15;10(1):408. doi: 10.1186/s13104-017-2739-x.

41.

Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry.

Westgeest HM, Uyl-de Groot CA, van Moorselaar RJA, de Wit R, van den Bergh ACM, Coenen JLLM, Beerlage HP, Hendriks MP, Bos MMEM, van den Berg P, van de Wouw AJ, Spermon R, Boerma MO, Geenen MM, Tick LW, Polee MB, Bloemendal HJ, Cordia I, Peters FPJ, de Vos AI, van den Bosch J, van den Eertwegh AJM, Gerritsen WR.

Eur Urol Focus. 2018 Sep;4(5):694-701. doi: 10.1016/j.euf.2016.09.008. Epub 2016 Oct 13.

PMID:
28753794
42.

TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.

Hamidi A, Song J, Thakur N, Itoh S, Marcusson A, Bergh A, Heldin CH, Landström M.

Sci Signal. 2017 Jul 4;10(486). pii: eaal4186. doi: 10.1126/scisignal.aal4186.

PMID:
28676490
43.

A Survey of Female Sexual Functioning in the General Dutch Population.

Lammerink EAG, de Bock GH, Pascal A, van Beek AP, van den Bergh ACM, Sattler MGA, Mourits MJE.

J Sex Med. 2017 Jul;14(7):937-949. doi: 10.1016/j.jsxm.2017.04.676.

PMID:
28673436
45.

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlström H, Bill-Axelson A, Birgisson H, Björ O, Edqvist PH, Hansson T, Helleday T, Hellman P, Henriksson K, Hesselager G, Hultdin M, Häggman M, Höglund M, Jonsson H, Larsson C, Lindman H, Ljuslinder I, Mindus S, Nygren P, Pontén F, Riklund K, Rosenquist R, Sandin F, Schwenk JM, Stenling R, Stålberg K, Stålberg P, Sundström C, Thellenberg Karlsson C, Westermark B, Bergh A, Claesson-Welsh L, Palmqvist R, Sjöblom T.

Acta Oncol. 2018 Feb;57(2):187-194. doi: 10.1080/0284186X.2017.1337926. Epub 2017 Jun 20.

PMID:
28631533
46.

Metastatic spinal cord compression as the first sign of malignancy.

Wänman J, Grabowski P, Nyström H, Gustafsson P, Bergh A, Widmark A, Crnalic S.

Acta Orthop. 2017 Aug;88(4):457-462. doi: 10.1080/17453674.2017.1319179. Epub 2017 May 11.

47.

Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.

Strömvall K, Thysell E, Halin Bergström S, Bergh A.

PLoS One. 2017 May 4;12(5):e0176679. doi: 10.1371/journal.pone.0176679. eCollection 2017.

48.

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.

Nordstrand A, Bergström SH, Thysell E, Bovinder-Ylitalo E, Lerner UH, Widmark A, Bergh A, Wikström P.

Clin Exp Metastasis. 2017 Apr;34(3-4):261-271. doi: 10.1007/s10585-017-9848-8. Epub 2017 Apr 26.

49.

Inertial sensor-based system for lameness detection in trotting dogs with induced lameness.

Rhodin M, Bergh A, Gustås P, Gómez Álvarez CB.

Vet J. 2017 Apr;222:54-59. doi: 10.1016/j.tvjl.2017.02.004. Epub 2017 Feb 10.

50.

Self-Management Support Needs of Patients with Chronic Diseases in a South African Township: A Qualitative Study.

Dube L, Rendall-Mkosi K, Van den Broucke S, Bergh AM, Mafutha NG.

J Community Health Nurs. 2017 Jan-Mar;34(1):21-31. doi: 10.1080/07370016.2017.1260983.

PMID:
28156143

Supplemental Content

Support Center